Thomson Reuters Corp. Stock Rises Friday, Outperforms Market
Dow Jones2026/10/09 20:36This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Thomson Reuters Corp. TRI rallied 1.97% to C$147.30 Friday, in what proved to be an all-around favorable trading session for the Canadian market, with the S&P/TSX Composite Index rising 1.48% to 35,664.62. Thomson Reuters Corp. closed 36.0% below its 52-week high of C$230.00, which the company reached on October 24th. Trading volume of 484,542 shares remained below its 50-day average volume of 669,951. Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires October 09, 2026 16:36 ET (20:36 GMT)
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Thomson Reuters Corp. TRI rallied 1.97% to C$147.30 Friday, in what proved to be an all-around favorable trading session for the Canadian market, with the S&P/TSX Composite Index rising 1.48% to 35,664.62.
Thomson Reuters Corp. closed 36.0% below its 52-week high of C$230.00, which the company reached on October 24th.
Trading volume of 484,542 shares remained below its 50-day average volume of 669,951.
Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 09, 2026 16:36 ET (20:36 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BMO raises target price for cybersecurity stocks
Needham raises CrowdStrike target price to $310
Morgan Stanley raises CME Group price target to $337